ClinicalTrials.Veeva

Menu

Reverse Electrical Remodeling of Native Conduction in Cardiac Resynchronization Therapy (RER-CRT)

Johns Hopkins University logo

Johns Hopkins University

Status

Completed

Conditions

Heart Failure
Patients Undergoing CRT-D Device Implantation

Study type

Observational

Funder types

Other

Identifiers

NCT01924221
NA_00065477

Details and patient eligibility

About

Cardiac resynchronization therapy with pacemaker alone, or in combination with a cardioverter-defibrillator, prolongs life and decreases risk of heart failure exacerbation in patients with low ejection fraction and wide QRS. Some patients achieve decrease in QRS duration 6 months after cardiac resynchronization therapy. Such phenomenon is called reverse electrical remodeling of native conduction. Retrospective analysis showed that reverse electrical remodeling of the native conduction after at least 6 months of CRT is associated with decreased rate of ventricular arrhythmias and better survival. This study is designed to study reverse electrical remodeling prospectively.

Enrollment

31 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients undergoing implantation of a CRT-D

Exclusion criteria

  • age < 18 y
  • pregnancy or planned pregnancy

Trial design

31 participants in 1 patient group

CRT
Description:
Patients with implanted cardiac resynchronization therapy defibrillator

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems